Breast Cancer

Repurposing irinotecan

Prioritising patients for breast cancer surgery during COVID-19: a surgeon’s perspective

Prioritising patients for breast cancer surgery during COVID-19: new treatment algorithm

CDK4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer

DS-8201 + pembro in patients HER2+ breast and NSCLC

Management of patients with breast cancer during COVID-19

Unanswered questions in breast cancer

Breast cancer highlights from ASCO 2020

Clinical applications of circulating tumor cells

ALTERNATE: fulvestrant and/or anastrozole in ER+ HER2- postmenopausal breast cancer

HER2CLIMB: tucatinib with trastuzumab and capecitabine for HER2+ breast cancer with brain metastases

KEYNOTE-355: pembrolizumab in triple-negative breast cancer

LILAC: comparing cardiac safety of ABP 980 with trastuzumab

Characterizing the immune microenvironment before and following anti-HER2 neoadjuvant therapy

Decision-making process for patients involved in clinical trials

Radiomics in the prediction of immunophenotypes in male breast cancer